AstraZeneca Gothenburg is one of AstraZeneca’s three global, strategic R&D centres. The site is home to expertise and capabilities across all areas of pharmaceutical development: from discovery science to the finished medicines used in clinical trials and ultimately by patients.
Our proximity to bioscience clusters in Gothenburg, Gaithersburg and Cambridge are a key element in our work to achieve scientific leadership and to transform our culture and the way we carry out our science. Through our Gothenburg site we have strong links to important hospitals and research institutions in Sweden, across the Nordic region and beyond. In Sweden, our researchers work in close partnership with all the leading Swedish academic centres. Gothenburg benefits from its vicinity to the Sahlgrenska University Hospital, one of the largest hospitals in Europe, and its connections with, for example, the Karolinska Institute and the Science for Life Laboratory, are also very significant.
Partnering with us
Through our Gothenburg site we play an active part in developing the ecosystem for life sciences and seek out new ways to collaborate and partner with other organisations across the region.
To explore our Gothenburg site further and learn more about our people, visit our dedicated page here.